Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Web Exclusives
Lung Cancer
,
Oncology
EGFR Most Common Mutation in Women with Lung Cancer and No Smoking History
Walter Alexander
Read More
Breast Cancer
,
Oncology
Sacituzumab Govitecan Improves Progression-Free Survival in Metastatic Triple-Negative Breast Cancer with Brain Metastases
Phoebe Starr
Read More
Breast Cancer
,
Oncology
First-Line Pembrolizumab plus Chemotherapy Extend Progression-Free Survival in Patients with Metastatic Triple-Negative Breast Cancer
Phoebe Starr
Read More
FDA Approvals
Cosela First CDK4/6 Inhibitor FDA Approved to Reduce Chemotherapy-Induced Myelosuppression
Read More
FDA Approvals
Vyxeos Now Indicated for Treatment of Pediatric Patients with AML
Read More
FDA Approvals
,
Lymphoma
FDA Approved Ukoniq, New Targeted Therapy, for Marginal-Zone and Follicular Lymphoma
Read More
FDA Approvals
,
Lymphoma
FDA Approved Breyanzi, Novel CAR T-Cell Therapy, for Large B-Cell Lymphoma
Read More
FDA Approvals
,
Multiple Myeloma
,
Oncology
FDA Approved Pepaxto for Relapsed or Refractory Multiple Myeloma
Read More
FDA Approvals
,
Multiple Myeloma
,
Oncology
FDA Approved Abecma, First CAR T-Cell Therapy for Multiple Myeloma
Read More
ESMO 2020 Highlights
Sotorasib, First-in-Class KRAS G12C Inhibitor, Hailed as “Triumph of Drug Discovery”
Phoebe Starr
Read More
11
12
13
14
15
16
17
Page 14 of 37
Results 131 - 140 of 368